Treatment for Hip Revision Surgery

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hip Revision Surgery
Eligibility
18 - 85
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the long-term outcomes of two types of hip replacement surgeries.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Fisetin
1
Optimum Cup Orientation
1
Total Hip Arthroplasty

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 5 years

5 years
Number of cases that had successful revision with Trident II Acetabular Shell of a Total Hip Replacement
Year 10
Radiographic Migration
Radiographic Radiolucency

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Fisetin
1
Optimum Cup Orientation
1
Total Hip Arthroplasty

Trial Design

0 Treatment Group

347 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

Stryker OrthopaedicsLead Sponsor
60 Previous Clinical Trials
18,471 Total Patients Enrolled

Eligibility Criteria

Age 18 - 85 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are willing and able to comply with postoperative scheduled clinical and radiographic evaluations.
You have been informed that you will be asked to participate in this study.\n
Patient is a candidate for a revision of a failed acetabular component with a cementless acetabular component.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top